Posts of Sam Shahrokhi
Company News
Core One Labs’ Vocan Initiates Engineering and Design of a Proprietary Production System for Manufacturing of API-Grade DMT
April 21, 2021
Vancouver, British Columbia, Canada – April 21, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or ”Core One”)...
Read more
Company News
Core One Labs Negotiates Milestone Acquisition With Akome Biotech Ltd.
April 17, 2021
Vancouver, British Columbia, Canada – April 17, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) a biotechnology research and development...
Read more
Company News
Core One Labs to Rescind Share Exchange with Plant-Based Investment Corp.
April 14, 2021
Vancouver, British Columbia, Canada – April 14, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or ”Core One”)...
Read more
Company News
Core One Labs Vocan Expands Product Commercialization Team
April 06, 2021
Vancouver, British Columbia, Canada – April 6, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”)...
Read more
Company News
Core One Labs Completes Acquisition of Ketamine Infusions Centers of Texas Representing the Company’s First Psychedelics Clinic in the U.S. and Announces Fast Entry Inclusion in The Horizons Psychedelic ETF
March 31, 2021
Vancouver, British Columbia, Canada – March 31, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (“Core One” or the “Company”),...
Read more
Company News
Core One Labs Appoints Dr. Stephen Peach as Head of Patient Research
March 28, 2021
Vancouver, British Columbia, Canada – March 28, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is pleased to announce...
Read more